Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Gut

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 25%Low 2 · 50%Moderate 1 · 25%High 0 · 0%

H. pylori persistence, PAN subgroup · patients with Helicobacter pylori infection

PPI triple therapy for 10 days showed no clear difference in H. pylori persistence, PAN subgroup compared with 7 days (low certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.85 [0.65, 1.12]
4 studies · 573 participants
Low

H. pylori persistence, PAN subgroup · patients with Helicobacter pylori infection

PPI triple therapy for 14 days showed no clear difference in H.pylori persistence, PAN subgroup compared with 10 days (low certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.79 [0.54, 1.15]
4 studies · 515 participants
Low

H. pylori persistence, PAN subgroup · patients with Helicobacter pylori infection

PPI triple therapy for 14 days probably leads to lower H. pylori persistence, PAN subgroup compared with 7 days (moderate certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.67 [0.52, 0.86]
10 studies · 1066 participants
Moderate

H. pylori persistence, PANi subgroup · patients with Helicobacter pylori infection

It is very uncertain whether PPI triple therapy for 10 days changes H. pylori persistence, PANi subgroup compared with 7 days (very low certainty).

1 finding from 1 review

Optimum duration of regimens for Helicobacter pylori eradication 2013 · Cochrane Headline outcomes only
RR 0.79 [0.52, 1.2]
1 study · 290 participants
Very low